Fideuram Asset Management Ireland dac Makes New $5.66 Million Investment in Teleflex Incorporated $TFX

Fideuram Asset Management Ireland dac bought a new position in Teleflex Incorporated (NYSE:TFX) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm bought 50,387 shares of the medical technology company’s stock, valued at approximately $5,662,000. Fideuram Asset Management Ireland dac owned approximately 0.11% of Teleflex at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. AQR Capital Management LLC increased its holdings in shares of Teleflex by 478.1% during the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after buying an additional 1,956,811 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Teleflex by 0.3% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,245,614 shares of the medical technology company’s stock worth $152,408,000 after buying an additional 3,812 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Teleflex by 10.6% during the 4th quarter. Geode Capital Management LLC now owns 985,684 shares of the medical technology company’s stock worth $120,312,000 after buying an additional 94,679 shares during the last quarter. Abrams Bison Investments LLC acquired a new stake in shares of Teleflex during the 3rd quarter worth approximately $112,317,000. Finally, Thrivent Financial for Lutherans increased its holdings in shares of Teleflex by 40.6% during the 4th quarter. Thrivent Financial for Lutherans now owns 774,034 shares of the medical technology company’s stock worth $94,463,000 after buying an additional 223,585 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Wells Fargo & Company raised their price target on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a report on Friday, May 8th. Truist Financial reiterated a “hold” rating and issued a $143.00 target price (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Bank of America upgraded shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price for the company in a report on Monday, April 13th. Zacks Research upgraded shares of Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Finally, Wall Street Zen downgraded shares of Teleflex from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Three analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Teleflex currently has a consensus rating of “Hold” and a consensus target price of $144.00.

Teleflex Stock Performance

NYSE:TFX opened at $129.64 on Friday. The company has a fifty day simple moving average of $124.46 and a two-hundred day simple moving average of $117.29. The company has a market cap of $5.74 billion, a price-to-earnings ratio of -5.69, a price-to-earnings-growth ratio of 0.97 and a beta of 0.82. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $139.67.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping the consensus estimate of $1.21 by $0.18. The business had revenue of $548.30 million during the quarter, compared to the consensus estimate of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The company’s quarterly revenue was up 32.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities analysts anticipate that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be paid a $0.34 dividend. The ex-dividend date is Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s payout ratio is -5.96%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.